Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Bradford Scientists developing lifesaving vaccine for newborns

06.10.2005


Microbiologists from the University of Bradford believe they may be closer to developing a vaccine that can protect newborn babies from being infected by the common and potentially fatal bacteria Group B Streptococcus.



Group B Streptococcus (GBS) are the most common bacteria attacking newborn babies, affecting 1 in 1000 births, and killing up to 6 per cent of those infected. It infects around 700 babies in the UK each year and kills around 100 of those infected, according to the national charity Group B Strep Support (GBSS).

GBS can cause pneumonia, blood infections and meningitis, and seriously ill babies can die within 24 hours of birth. Babies catch the bacteria from colonised mothers around the time of delivery. Pregnant women may be unaware that they are carrying GBS as usually there are no symptoms.


Beverley Bray (25), a PhD student from the Department of Biomedical Sciences at the University of Bradford, is focussing her studies on this vaccine under the supervision of research leader Dr Dean Harrington.

Research by Mrs Bray and Dr Harrington has focused on structures on the bacterium’s surface – lipoproteins – which they think may be important in several processes, including attaching GBS to the baby’s own cells.

Mrs Bray said: “At the moment, we don’t know why GBS is so virulent, so we need to understand how it sticks itself to a baby’s cell surfaces to give us a chance of creating a vaccine.

“If, ultimately, we can develop an effective vaccine from lipoproteins, we could prevent colonised mothers from transmitting the bacteria to newborns. This will remove the need to treat large numbers of mothers and babies with antibiotics.”

In their studies, the University’s microbiologists have looked at a closely related species of Streptococcus that attacks horses, and created a strain that does not produce lipoproteins. They showed that this changes the bacterium’s ability to cause disease, making lipoproteins a possible route for creating a vaccine.

Jane Plumb, Chairman and Co-founder of the charity Group B Strep Support, said: “Up to a third of all men and women carry GBS in their intestines without symptoms and roughly a quarter of women of childbearing age carry GBS in the vagina at any one time.

“A safe and reliable vaccine against GBS infection in babies would be brilliant. It could protect more babies from these infections than any methods we currently have. It could also overcome some of the main problems with screening women for GBS carriage and treating them in labour.

“Some mums will always miss out on screening, and others will have such fast labours they won’t get adequate treatment before delivery. A vaccine could mean many mothers and their babies wouldn’t need antibiotics, which has got to be good news.”

Mrs Bray presented interim results of her research at a recent meeting of the Society of General Microbiologists at Keele University in Staffordshire. Initial findings of the research are expected to be published in 2006.

Emma Banks | alfa
Further information:
http://www.bradford.ac.uk

More articles from Health and Medicine:

nachricht Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences

nachricht What does congenital Zika syndrome look like?
24.03.2017 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>